If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Education/Academic qualification

PhD, University of Minnesota Twin Cities

Sep 1 1992Dec 31 1996

MD, Charles University

Sep 1 1984Sep 27 1990

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 72 Similar Profiles
Mucopolysaccharidosis I Medicine & Life Sciences
Epidermolysis Bullosa Dystrophica Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences
Transplants Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Epidermolysis Bullosa Medicine & Life Sciences
Mesenchymal Stromal Cells Medicine & Life Sciences
Induced Pluripotent Stem Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1994 2023

Research Output 1996 2019

A homozygous frameshift variant in the KRT5 gene is compatible with life and results in severe recessive epidermolysis bullosa simplex

Tryon, R. K., Tolar, J., Preusser, S. M., Riddle, M. J., Keene, D. R., Bower, M., Thyagarajan, B. & Ebens, C., Jul 1 2019, In : JAAD Case Reports. 5, 7, p. 576-579 4 p.

Research output: Contribution to journalArticle

Open Access
Epidermolysis Bullosa Simplex
Keratin-5
Keratins
Genes
Autosomal Recessive Epidermolysis Bullosa Simplex
1 Citation (Scopus)
Epidermolysis Bullosa Dystrophica
Cyclophosphamide
Bone Marrow
Tissue Donors
Transplants

Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation

Polgreen, L. E., Lund, T. C., Braunlin, E. A., Tolar, J., Miller, B. S., Fung, E., Whitley, C. B., Eisengart, J., Northrop, E., Rudser, K., Miller, W. P. & Orchard, P. J., Jan 1 2019, (Accepted/In press) In : Pediatric Research.

Research output: Contribution to journalArticle

Open Access
Mucopolysaccharidosis I
Cell Transplantation
Clinical Trials
Anti-Idiotypic Antibodies
Pharmaceutical Preparations

Erratum: Correction: Rapid DNA replication origin licensing protects stem cell pluripotency (eLife (2017) 6 PII: e49040)

Matson, J. P., Dumitru, R., Coryell, P., Baxley, R. M., Chen, W., Twaroski, K., Webber, B. R., Tolar, J., Bielinsky, A. K., Purvis, J. E. & Cook, J. G., Jun 5 2019, In : eLife. 8

Research output: Contribution to journalComment/debate

Open Access
Replication Origin
Licensure
Chromosomes
Stem cells
DNA Replication